SCHEMBL25583833

SCHEMBL25583833

COC(=O)C(C=O)(C(=O)OC)c1cc(OC)nc(C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP1A2 P05177 1/20 0.37
▸ PDE2A O00408 1/20 0.37
▸ POLB P06746 1/20 0.34
▸ LMNA P02545 3/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ TP53 P04637 2/20 0.32
▸ EDNRB P24530 1/20 0.32
▸ EDNRA P25101 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ MAPT P10636 3/20 0.32
▸ GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24940652 0.80 ALDH1A1 (0.42) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL25584937 0.79 ALDH1A1 (0.41) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL24111471 0.71 PDE2A (0.46) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL17194951 0.70 PDE2A (0.48) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL13012210 0.69 GAA (0.50) ALDH1A1KDM4EPDE2APOLBLMNA
SCHEMBL423183 0.67 PDE2A (0.61) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL9423136 0.66 ALDH1A1 (0.56) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL9196259 0.66 CYP1A2 (0.53) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL31708108 0.65 PDE2A (0.51) ALDH1A1KDM4ECYP1A2PDE2APOLB
SCHEMBL25136509 0.64 LMNA (0.49) ALDH1A1KDM4ECYP1A2PDE2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174532-A1 METHODS FOR ANTAGONIZING A MELANOCORTIN 4 RECEPTOR PFIZER INC. (US) 2023-06-08 — — US disclosed
US-11643412-B2 Melanocortin 4 receptor antagonists and uses thereof PFIZER INC. (US) 2023-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174532-A1 METHODS FOR ANTAGONIZING A MELANOCORTIN 4 RECEPTOR MC4R, MC2R, NPY4R ALDH1A1 3488/4885KDM4E 1189/4885CYP1A2 2744/4885
US-11643412-B2 Melanocortin 4 receptor antagonists and uses thereof MC4R, MC3R, MC5R ALDH1A1 4397/4885KDM4E 961/4885CYP1A2 2255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback